Telix Pharmaceuticals Limited announced an agreement to acquire ITM Isotope Technologies Munich SE, according to source material published on September 21, 2026. The reported purchase consideration is $0. The reported stake is 76.3%. This summary is limited to the approved transaction facts in the cited source evidence.
Telix Pharmaceuticals Limited announced an agreement to acquire ITM Isotope Technologies Munich SE
Telix Pharmaceuticals Limited announced an agreement to acquire ITM Isotope Technologies Munich SE
AcquisitionManufacturingDE
Get the full ITM Isotope Technologies Munich SE company profile
Access contacts, investors, buying signals & more
Acquired
ITM Isotope Technologies Munich SE
GermanyManufacturing
Undisclosed amount
September 21, 2026
Acquirer
Telix Pharmaceuticals Limited
Pharmaceutical Manufacturing
Unlock GTM signals
Discover ITM Isotope Technologies Munich SE's tech stack and active buying intent.
Unlock key decision-makers
Get direct access to the decision-makers at ITM Isotope Technologies Munich SE.